A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects
Clinical trial NCT03239353 · COMPLETED
Trial details
- NCT number
- NCT03239353
- Sponsor
- Aucta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2018-05-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.